International Stem Cell annual return on equity
2007
2008
2010
2011
2012
2015
2016
2017
2018
International Stem Cell Return on Equity (ROE) Growth & History (ISCO)
International Stem Cell's return on equity was −92.63% for fiscal 2018.
View full International Stem Cell company overviewInternational Stem Cell annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | −92.63% | +127.74 pp |
| 2017 | 2017-12-31 | −220.37% | −177.54 pp |
| 2016 | 2016-12-31 | −42.83% | +232.36 pp |
| 2015 | 2015-12-31 | −275.20% | — |
| 2012 | 2012-12-31 | −1,054.48% | −850.95 pp |
| 2011 | 2011-12-31 | −203.53% | +612.31 pp |
| 2010 | 2010-12-31 | −815.84% | — |
| 2008 | 2008-12-31 | −2,037.52% | −1790.14 pp |
| 2007 | 2007-12-31 | −247.38% | — |
International Stem Cell quarterly return on equity
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q1.15
Q2.15
Q3.15
Q4.15
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2019 | 2019-03-31 | −127.34% | −82.51 pp |
| Q4 2018 | 2018-12-31 | −38.62% | +109.30 pp |
| Q3 2018 | 2018-09-30 | 5.46% | +313.07 pp |
| Q2 2018 | 2018-06-30 | −24.01% | −74.93 pp |
| Q1 2018 | 2018-03-31 | −44.83% | +106.27 pp |
| Q4 2017 | 2017-12-31 | −147.92% | −259.63 pp |
| Q3 2017 | 2017-09-30 | −307.60% | — |
| Q2 2017 | 2017-06-30 | 50.92% | — |
| Q1 2017 | 2017-03-31 | −151.10% | — |
| Q4 2016 | 2016-12-31 | 111.71% | +237.90 pp |
| Q4 2015 | 2015-12-31 | −126.19% | — |
| Q3 2015 | 2015-09-30 | −65.77% | — |
| Q2 2015 | 2015-06-30 | 199.17% | — |
| Q1 2015 | 2015-03-31 | −1,063.64% | — |
| Q3 2012 | 2012-09-30 | −224.97% | −173.39 pp |
| Q2 2012 | 2012-06-30 | −93.33% | −46.48 pp |
| Q1 2012 | 2012-03-31 | −73.42% | — |
| Q4 2011 | 2011-12-31 | −59.87% | — |
| Q3 2011 | 2011-09-30 | −51.58% | — |
| Q2 2011 | 2011-06-30 | −46.85% | — |
International Stem Cell return on equity trends
Between the periods ended 2007-12-31 and 2018-12-31, International Stem Cell's return on equity increased from −247.38% to −92.63%, a change of +154.75 percentage points. The latest reported quarter, Q1 2019, shows −127.34%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review International Stem Cell source filings ↗